Acupuncture of chronic headache disorders in primary care: randomised controlled trial and economic analysis
Vickers et al. · Health Technology Assessment · 2004
Evidence Level
STRONGOBJECTIVE
To determine the effects of a 'use acupuncture' versus 'avoid acupuncture' policy for chronic headaches in primary care
WHO
401 patients with chronic headache (mainly migraine) in primary care
DURATION
12-month follow-up after 3 months of treatment
POINTS
Points individualized according to traditional Chinese medicine
🔬 Study Design
Acupuncture
n=205
Up to 12 acupuncture sessions over 3 months + standard care
Control
n=196
Standard general practitioner care
📊 Results in numbers
Reduction in headache score
Equivalent reduction in headache days per year
Reduction in medication use
Cost per QALY
Percentage highlights
📊 Outcome Comparison
Headache score at 12 months
Medication reduction
This large study shows that acupuncture can significantly help people with chronic headaches, especially migraine. Patients who received acupuncture had fewer days of pain per year, used less medication, and missed fewer days of work.
Article summary
Plain-language narrative summary
This study represents an important milestone in research on acupuncture for chronic headaches, being one of the largest randomized clinical trials ever conducted in this area. The research included 401 patients with chronic headache recruited directly from primary care in the United Kingdom, the majority diagnosed with migraine. The study design was pragmatic, comparing a policy of offering acupuncture versus avoiding acupuncture, reflecting real-world decisions. Treatments were individualized according to the principles of traditional Chinese medicine, with points selected according to each patient's assessment.
The control group received usual care from their general practitioners but was instructed to avoid acupuncture during the study.
The results were impressive and clinically relevant. In the primary outcome, the headache score at 12 months was significantly lower in the acupuncture group (34% reduction versus 16% in the control). This difference corresponds to approximately 22 fewer headache days per year. Importantly, the benefits were lasting, with improvement maintained even after the end of treatment, suggesting prolonged effects of acupuncture.
The benefits extended beyond pain reduction. Patients who received acupuncture used 15% less medication, made 25% fewer medical visits, and missed 15% fewer days of work due to headaches. Quality of life, measured by the SF-36 questionnaire, also improved, especially in the domains of physical functioning, energy, and perceived change in health.
The economic analysis showed that, although acupuncture has initial costs, it is cost-effective at £9,180 per quality-adjusted life year (QALY) gained. This value is well below the £30,000 per QALY threshold considered acceptable by the British health system, indicating good cost-benefit. The probability of acupuncture being cost-effective was estimated at 92% at this threshold.
The effects were more pronounced in patients with migraine compared with those with tension-type headache, and interestingly, patients with more severe symptoms at baseline showed greater benefits. Safety was excellent, with only five mild cases of post-treatment headache reported as adverse effects.
This study provides robust evidence that acupuncture offers clinically significant and lasting benefits for patients with chronic headache in primary care. The pragmatic approach of the study increases the external validity of the results, making them more applicable to real clinical practice. Limitations include the absence of placebo control and possible response bias, although several measures were taken to minimize these problems.
Strengths
- 1Large sample size with adequate statistical power
- 2Pragmatic design reflecting real clinical decisions
- 3Long follow-up of 12 months
- 4Rigorous economic analysis included
- 5Multiple measures to reduce bias
Limitations
- 1No placebo group (sham needling control)
- 2Possible response bias due to lack of blinding
- 3Few patients with tension-type headache for specific analysis
- 4Prescribed-medication analysis limited to a subgroup
Expert Commentary
Dr. Marcus Yu Bin Pai
MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture
▸ Clinical Relevance
For those working in pain or rehabilitation services, this trial by Vickers et al. offers a solid argument for incorporating acupuncture into the management of chronic headache in primary care and specialty clinics. The 34% reduction in headache score, equivalent to 22 fewer days of pain per year, is an outcome any clinician recognizes as significant for the patient who arrives at the office overwhelmed by frequent attacks. The 15% reduction in medication use is particularly relevant for the population with medication-overuse headache, a cycle that often complicates management. The cost of £9,180 per QALY places acupuncture well within accepted cost-effectiveness thresholds, which strengthens the conversation with administrators about resource incorporation. Patients with chronic migraine refractory to first-line pharmacologic prophylaxis, or with intolerance to beta-blockers and tricyclic antidepressants, configure the profile in which this treatment positions itself most naturally within the available arsenal.
▸ Notable Findings
The finding that deserves special attention is the durability of the effect: benefits were maintained throughout the 12 months of follow-up, even after the end of sessions in the first 3 months. This suggests that acupuncture functions not only as short-term analgesia but induces functional modifications with prolonged clinical impact, consistent with central modulation mechanisms described in the pain neurophysiology literature. The subgroup with more severe baseline symptoms showed proportionally greater gains, which inverts the logic of reserving acupuncture only for mild cases. The improvement in SF-36, particularly in the domains of energy and physical functioning, captures dimensions that the simple recording of headache days does not encompass. The 92% probability of cost-effectiveness at the British threshold is a number that translates well from the research domain to that of health policy and institutional justification.
▸ From My Experience
In my practice at the pain clinic, chronic headache patients with migraine are individuals who have tried at least two or three prophylactic regimens before reaching us. I usually incorporate acupuncture as an adjuvant to ongoing drug treatment, not as a substitute. The initial response usually appears between the third and fifth sessions, with a noticeable reduction in attack frequency; patients with greater pain burden at baseline, exactly the subgroup that responded best in this study, tend to notice this change more clearly. I routinely work with 10 to 12 sessions in the acute phase and, depending on progress, maintain monthly reinforcement sessions for another 3 to 6 months. I combine treatment with guidance on sleep hygiene, trigger management, and, when there is an associated cervicogenic component, with physical therapy directed at the suboccipital musculature. I avoid starting acupuncture in patients still in analgesic overuse without first addressing that pattern. The profile that responds best, in my observation, is precisely that of the motivated patient with high-frequency episodic migraine transitioning to chronic, still without established medication dependence.
Indexed scientific article
This study is indexed in an international scientific database. Check your institutional access to obtain the full article.
Scientific Review
Marcus Yu Bin Pai, MD, PhD
CRM-SP: 158074 | RQE: 65523 · 65524 · 655241
PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.
Learn more about the author →Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.
Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.
Related articles
Based on this article’s categories